NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE- neomycin, polymyxin b sulfates, dexamethasone ointment United States - English - NLM (National Library of Medicine)

neomycin and polymyxin b sulfates and dexamethasone- neomycin, polymyxin b sulfates, dexamethasone ointment

proficient rx lp - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - dexamethasone 1 mg in 1 g - for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitises is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns; or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drugs in this product is active against the following common bacterial eye pathogens: staphylococcus aureus, escherichia coli, haemophilusinfluenzae, klebsiella/enterobacter sp

NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE- neomycin, polymyxin b sulfates, dexamethasone ointment United States - English - NLM (National Library of Medicine)

neomycin and polymyxin b sulfates and dexamethasone- neomycin, polymyxin b sulfates, dexamethasone ointment

padagis us llc - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - dexamethasone 1 mg in 1 g - for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns; or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drug in this product is active against the following common bacterial eye pathogens: staphylococcus aureus, escherichia coli, haemophilus influenzae, klebsiella/enterobacter

NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE- neomycin, polymyxin b sulfates, dexamethasone ointment United States - English - NLM (National Library of Medicine)

neomycin and polymyxin b sulfates and dexamethasone- neomycin, polymyxin b sulfates, dexamethasone ointment

preferred pharmaceuticals, inc. - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - dexamethasone 1 mg in 1 g - for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns; or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drug in this product is active against the following common bacterial eye pathogens: staphylococcus aureus, escherichia coli, haemophilus influenzae, klebsiella/enterobacter

NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE- dexamethasone, neomycin sulfate, polymysin b sulfate ointment United States - English - NLM (National Library of Medicine)

neomycin and polymyxin b sulfates and dexamethasone- dexamethasone, neomycin sulfate, polymysin b sulfate ointment

putney, inc. - dexamethasone (unii: 7s5i7g3jql) (dexamethasone - unii:7s5i7g3jql), neomycin sulfate (unii: 057y626693) (neomycin - unii:i16qd7x297), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - dexamethasone 1 mg in 1 g - for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or risk of bacterial ocular infection exists. ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitises is accepted to obtain a diminution in edema and inflammation. they are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns; or penetration of foreign bodies. the use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. the particular anti-infective drugs in this product is active against the following common bacterial eye pathogens: staphylococcus aureus, escherichia coli, haemophilus influenzae, klebsiella/enterobacter

Dexamethasone Phosphate Krka 4 mg/ml solution for injection/infusion Ireland - English - HPRA (Health Products Regulatory Authority)

dexamethasone phosphate krka 4 mg/ml solution for injection/infusion

krka, d.d., novo mesto - dexamethasone sodium phosphate - solution for injection/infusion - 4/1 milligram(s)/millilitre - glucocorticoids; dexamethasone

Dexamethasone New Zealand - English - Medsafe (Medicines Safety Authority)

dexamethasone

douglas pharmaceuticals limited - dexamethasone 1mg - tablet - 1 mg - active: dexamethasone 1mg excipient: lactose monohydrate magnesium stearate maize starch polyvidone 30 purified talc sodium starch glycolate

Dexamethasone New Zealand - English - Medsafe (Medicines Safety Authority)

dexamethasone

douglas pharmaceuticals limited - dexamethasone 4mg - tablet - 4 mg - active: dexamethasone 4mg excipient: lactose monohydrate magnesium stearate maize starch polyvidone 30 purified talc

Dexamethasone 2mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

dexamethasone 2mg tablets

aspen pharma trading limited - dexamethasone - tablet - 2 milligram(s) - glucocorticoids; dexamethasone

Dexamethasone phosphate 4mg/ml Solution for Injection or Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

dexamethasone phosphate 4mg/ml solution for injection or infusion

wockhardt uk limited - dexamethasone sodium phosphate - solution for injection/infusion - 4 milligram(s)/millilitre - glucocorticoids; dexamethasone - glucocorticoids - it e can be used for all forms of general and local glucocorticoid injection therapy and all acute conditions in which intravenous glucocorticoids may be life-saving.